Bristol-Myers Squibb
BMY
BMY
1,593 hedge funds and large institutions have $63.5B invested in Bristol-Myers Squibb in 2017 Q1 according to their latest regulatory filings, with 130 funds opening new positions, 616 increasing their positions, 646 reducing their positions, and 118 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,593
Holders Change
-4
Holders Change %
-0.25%
% of All Funds
39.72%
Holding in Top 10
45
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-23.73%
% of All Funds
1.12%
New
130
Increased
616
Reduced
646
Closed
118
Calls
$2.17B
Puts
$1.81B
Net Calls
+$358M
Net Calls Change
+$243M
Top Buyers
| 1 |
BlackRock
New York
|
$5.28B |
| 2 |
Morgan Stanley
New York
|
$1.12B |
| 3 |
Dodge & Cox
San Francisco,
California
|
$1.58B |
| 4 |
Renaissance Technologies
New York
|
$352M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
$8.3B |
Top Sellers
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
$276M |
| 2 |
Capital World Investors
Los Angeles,
California
|
$2.06B |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$1.28B |
| 4 |
JPMorgan Chase & Co
New York
|
$1.35B |
| 5 |
D.E. Shaw & Co
New York
|
$46.4M |
